Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 11
«Preious | of 3 |
1

Evidence of α-glucosidase inhibitorsfor Chinese type 2 diabetes patients

Drug Evaluation, , Issue 5,2015, Pages 27-30,46, doi:10.3969/j.issn.1672-2809.2015.05.008

2

行业动态

Drug Evaluation, , Issue 5,2015, Pages 5-5, doi:10.3969/j.issn.1672-2809.2015.05.002

3

会讯

Drug Evaluation, , Issue 5,2015, Pages 5-5, doi:10.3969/j.issn.1672-2809.2015.05.003

4

文摘

Drug Evaluation, , Issue 5,2015, Pages 4-4, doi:10.3969/j.issn.1672-2809.2015.05.001

5

Evidence of the efficacy and safety ofsulfonylureas in Chinese patients with type 2 diabetes

Drug Evaluation, , Issue 5,2015, Pages 19-22,41, doi:10.3969/j.issn.1672-2809.2015.05.006

Items 1-5 of 11
«Preious | of 3 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn